FDA strips cancer and heart warnings from three more menopause patches
The agency again skipped its usual advisory panels, drawing criticism from researchers who say the evidence has not been clearly justified. Prescriptions for estrogen patches have more than doubled in a year, and many patients still cannot fill them.